[ad_1]
Enviva Inc. (NYSE:EVA) (“Enviva”, “we” or “our”) announced today that it has priced an underwritten public offering (the “Offer”) of 4,300,000 shares of its common stock at $70.00 per share. Enviva has granted the underwriters a 30-day option to purchase up to 645,000 additional shares of common stock from Enviva.
The offering is expected to close on January 24, 2022, subject to customary closing conditions.
Enviva intends to use the net proceeds from the offering, including underwriter fees and estimated fees, for general corporate purposes, including pre-funding a portion of its capital expenditures related to ongoing development projects, as well as temporarily repaying debt.
Goldman Sachs & Co. LLC, Citigroup Global Markets Inc., JP Morgan Securities LLC, Barclays Capital Inc., BMO Capital Markets Corp., HSBC Securities (USA) Inc., RBC Capital Markets, LLC and Truist Securities, Inc. The joint bookrunners of the secondary offering. Loop Capital Markets LLC, Raymond James & Associates, Inc. and USCA Securities LLC acted as co-managers for the offering.
This offering is made pursuant to an effective shelf registration statement that has been filed with the U.S. Securities and Exchange Commission (“SEC”) and is automatically effective on January 19, 2022. This offering will be in preliminary form only. The prospectus supplement and accompanying base prospectus, copies of which are available on the SEC website: www.sec.gov. Alternatively, the Joint Lead Bookrunners will arrange to send you a preliminary prospectus supplement and a related base prospectus if you request it by contacting:
|
Goldman Sachs Attn: Prospectus Department, 200 West Street New York, NY 10282
Phone: 866-471-2526 e-mail: Prospectus – ny@ny.email.gs.com |
Citigroup Global Markets Inc.
Attn: Broadridge Financial Solutions
1155 Long Island Avenue, Edgewood, NY 11717
Phone: 800-831-9146 |
JPMorgan Securities LLC Attn: Broadridge Financial Solutions 1155 Long Island Avenue, Edgewood, NY 11717 Phone: 1-866-803-9204 e-mail: Prospectus – eq_fi@jpmchase.com |
This press release is neither an offer to sell…
The full story is available on Benzinga.com
[ad_2]
Source link
